Ocrevus-hcp.com

  1. Home
  2. Ocrevus-hcp.com

Multiple Sclerosis (MS) Treatment for RMS and PPMS

WEBLearn more about OCREVUS® (ocrelizumab) an IV infusion treatment for relapsing & primary progressive multiple sclerosis (RMS & PPMS). See full safety for more information.

Actived: 8 days ago

URL: https://www.ocrevus-hcp.com/about/ms-treatment-for-ppms-and-rms.html

Patient Experience OCREVUS® (ocrelizumab)

WEBOCREVUS can cause infusion reactions, which can include pruritus, rash, urticaria, erythema, bronchospasm, throat irritation, oropharyngeal pain, dyspnea, pharyngeal or …

Category:  Health Go Health

Relapsing MS and Primary Progressive MS Treatment OCREVUS® …

WEBPoster presented at: the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); October 26-28, 2022; Amsterdam, the …

Category:  Health Go Health

Efficacy for Relapsing Multiple Sclerosis (RMS)

WEBRelapses were defined as new or worsening neurologic symptoms that were attributable to multiple sclerosis, persisted for over 24 hours, were immediately preceded by a stable or …

Category:  Health Go Health

DOSING & ADMINISTRATION GUIDE

WEBmg MG 600 SUBSEQUENT DOSES INITIAL DOSE EVERY 6 MONTHS MG 300 1 Infusion 1 2.5 hours MG 300 15 Infusion 2 2.5 hours Single Infusion 2 hours or 3.5 to 4 hours 3 …

Category:  Health Go Health

Efficacy for Primary Progressive Multiple Sclerosis (PPMS)

WEBIn the PPMS trial, 70% of OCREVUS-treated patients experienced one or more infections compared to 68% of patients on placebo. OCREVUS increased the risk for upper …

Category:  Health Go Health

Financial Assistance Options OCREVUS® (ocrelizumab)

WEBWith the OCREVUS Co-pay Program, eligible patients with commercial insurance could pay as little as $0 per OCREVUS infusion. Co-pay assistance is provided up to $1,500 per …

Category:  Health Go Health

Important Safety Information for HCPs OCREVUS® (ocrelizumab)

WEBOCREVUS increased the risk for upper respiratory tract infections, lower respiratory tract infections, skin infections, and herpes-related infections. OCREVUS was not associated …

Category:  Health Go Health

Considerations for Composing a Letter of Medical Necessity

WEBRecommended information for a Letter of Medical Necessity includes: Full name • Insurance group number. Date of birth • Case ID number (if available) Insurance ID number. The …

Category:  Medical Go Health

HCP Practice Resources & Downloads OCREVUS® (ocrelizumab)

WEBIn the PPMS trial, 70% of OCREVUS-treated patients experienced one or more infections compared to 68% of patients on placebo. OCREVUS increased the risk for upper …

Category:  Health Go Health

Dosing & Administration OCREVUS® (ocrelizumab)

WEBThree treatments in the first year: first 600-mg dose administered as two 300-mg IV infusions over approximately 2.5 hours, separated by 2 weeks; subsequent doses …

Category:  Health Go Health

Infusion Site Options OCREVUS® (ocrelizumab)

WEBIf you’re looking for support in finding an infusion site—including home infusions—you can always contact your OCREVUS representative or Patient Navigator. To contact your …

Category:  Health Go Health

OCREVUS Start Form

WEBPlease follow these 3 steps to get started: Read “Authorization to Use and Disclose Personal Information” on page 3. Sign and date page 4. Please note you must sign the …

Category:  Health Go Health

Multiple Sclerosis (MS) Progression OCREVUS® (ocrelizumab)

WEBIndications. OCREVUS is indicated for the treatment of: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and …

Category:  Health Go Health

Helpful Resources for Your Practice OCREVUS® (ocrelizumab)

WEBStep 1: Print OCREVUS Start Form below and have your patient complete the patient consent section of this form. OCREVUS Start Form (English) Step 2: Submit the …

Category:  Health Go Health

Financial Support FAQs OCREVUS® (ocrelizumab)

WEBYou can check patient eligibility online. The financial assistance tool will guide the patient through some of their options and let them know which financial support programs may …

Category:  Health Go Health

Sign Up for OCREVUS® (ocrelizumab) Updates for HCPs

WEBOCREVUS can cause infusion reactions, which can include pruritus, rash, urticaria, erythema, bronchospasm, throat irritation, oropharyngeal pain, dyspnea, pharyngeal or …

Category:  Health Go Health

Patient Navigators OCREVUS® (ocrelizumab)

WEBThe link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Thetford health and wellbeing

 › Health care for artists uk

 › Public health jobs hired

 › Brain health restoration arrow right

 › Cox health ems locations

 › Health and wellbeing paintings

 › Health unit immunization records

 › Freedom behavioral health leesville

 › Health check in netapp

 › Metropolitan health group contact details

Recently Searched

 › Mental health and work stress

 › Mental health cooperative psychiatric services

 › African american maternal health 2023

 › Umr sutter health provider portal

 › Lutheran hospital behavioral health department

 › Focus health records request form

 › Uchealth adrenal cancer program

 › Iu health oncology carmel in

 › Unity behavioral health portland oregon

 › Health care marketplace open enrollment 2022